What is the recommended management of leptospirosis, including antibiotic choices for mild/moderate versus severe disease, supportive care, and prophylaxis for close contacts?

Management of Leptospirosis

For mild-to-moderate leptospirosis, treat with doxycycline 100 mg twice daily orally for 7 days, and for severe disease (Weil's disease with jaundice, renal failure, or hemorrhage), use intravenous penicillin or ceftriaxone for 7 days. Early antibiotic therapy during the bacteremic phase (first 5-7 days) is most effective, while late-phase treatment with organ dysfunction requires aggressive supportive care with uncertain antibiotic benefit 1, 2, 3.

Antibiotic Selection by Disease Severity

Mild-to-Moderate Disease

• First-line: Doxycycline 100 mg orally twice daily for 7 days 1, 3
• Alternative: Amoxicillin 500 mg orally three times daily for 7-10 days 1
• Alternative: Azithromycin (appears promising but less studied) 4

These patients present with flu-like symptoms, myalgia (especially calf pain), fever, and conjunctival suffusion without organ dysfunction 1.

Severe Disease (Weil's Disease)

Characterized by jaundice, hemorrhage (capillary fragility with often normal clotting studies), and hepatorenal failure 1:

• First-line: Intravenous penicillin (benzyl penicillin 1.5 million units every 6 hours) for 7 days 1, 2
• Alternative: Ceftriaxone 1 g IV every 24 hours or cefotaxime 1 g IV every 6 hours for 7 days 4
• Alternative: Doxycycline 100 mg IV twice daily (though concerns exist for severe disease) 4

Critical timing consideration: Treatment should be initiated immediately upon clinical suspicion during the bacteremic phase (first 5-7 days of symptoms). Antibiotics given after this window, when immune-mediated organ damage has occurred, show doubtful benefit 2, 5.

Supportive Care for Severe Disease

The management of critically ill leptospirosis patients follows standard sepsis principles 5:

Hemodynamic Support

• Fluid resuscitation: Conservative strategy (avoid fluid overload)
• Vasopressor support: Required in approximately 80% of ICU patients 5
• Blood pressure targets: Standard sepsis goals

Respiratory Support

• Mechanical ventilation: Lung-protective ventilation strategy when needed (approximately 27% of ICU patients) 5
• ARDS management: Standard protocols; ECMO may be considered for refractory cases 5

Renal Support

• Renal replacement therapy: Initiate using standard indications (approximately 20% of ICU patients require this) 5
• Monitor: Proteinuria and hematuria are common findings 1

Hematologic Management

• Transfusion: Restrictive strategy for blood products 5
• Hemorrhage: Due to capillary fragility, not coagulopathy—clotting studies often normal 1

Corticosteroids

• Limited role: Short-course hydrocortisone may be used for vasopressor-dependent shock (standard sepsis indication), but routine corticosteroid use is not supported 5

Diagnostic Confirmation

While treatment should begin on clinical suspicion, confirm diagnosis with:

• Early phase (first 5 days): Blood cultures (keep at room temperature before dispatch to reference lab) 1
• After day 6-10: IgM ELISA and microscopic agglutination test (MAT)
  • IgM titer ≥1:320 is suggestive
  • Titers 1:80-1:160 may represent early infection or cross-reactions
  • Convalescent serology (>10 days after onset) confirms diagnosis 1
• Urinalysis: May show proteinuria and hematuria 1
• Laboratory findings: Thrombocytopenia, polymorphonuclear leukocytosis, elevated bilirubin with mild transaminase elevation, renal dysfunction 1

Clinical clue: Conjunctival suffusion is highly suggestive of leptospirosis 1.

Prophylaxis

Post-Exposure Prophylaxis

Doxycycline 200 mg orally once weekly has been studied for high-risk exposures (soldiers in endemic areas during training), showing a number-needed-to-treat of 24 to prevent one symptomatic infection 6. However:

• Evidence limited to military populations in high-risk endemic settings
• Adverse effects occur in 3% (number-needed-to-harm: 39) 6
• Not routinely recommended for close contacts of cases—leptospirosis is not transmitted person-to-person 2

Primary Prevention

• Behavioral modifications: Avoid unnecessary contact with potentially contaminated water, especially during rainy season and after floods 3
• Personal protective equipment: For occupational exposures (farmers, veterinarians, sewer workers)
• Vaccines: Very few countries have licensed human vaccines; available vaccines only protect against rodent-associated serogroups 2

Common Pitfalls

1. Delayed diagnosis: Leptospirosis mimics many febrile illnesses. Consider in patients with water/animal exposure, especially with conjunctival suffusion and calf myalgia 1

2. Late antibiotic initiation: Antibiotics are most effective during the bacteremic phase (first 5-7 days). Once organ dysfunction develops, benefit is uncertain 2

3. Misinterpreting hemorrhage: Bleeding is due to capillary fragility, not coagulopathy—don't expect abnormal clotting studies 1

4. Aggressive fluid resuscitation: Use conservative fluid strategy to avoid pulmonary edema 5

5. Unnecessary prophylaxis: Close contacts do not require prophylaxis—disease is not person-to-person transmitted 2

Prognosis

With modern intensive care using standard sepsis management principles, mortality can approach 0% even in critically ill patients requiring ICU admission in well-resourced settings 5. However, in resource-limited settings, ICU mortality can exceed 50% 5. The key determinants of outcome are:

• Early recognition and treatment
• Access to organ support (mechanical ventilation, renal replacement therapy, vasopressors)
• Conservative fluid management
• Avoidance of complications through meticulous supportive care